Profile
Douglas E.
Feltner is a former VP & Global Head-Translational Medicine at Pfizer Inc., Vice President at Translational Medicine India, Inc., Chief Medical Officer at Embera NeuroTherapeutics, Inc., Vice President-Neuroscience Development at AbbVie, Inc., and Vice President-Clinical Development at Novartis Gene Therapies, Inc. He holds a doctorate degree from the University of Michigan Medical School.
Former positions of Douglas E. Feltner
| Companies | Position | End |
|---|---|---|
| EXICURE, INC. | Chief Tech/Sci/R&D Officer | 2022-01-30 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ABBVIE INC. | Corporate Officer/Principal | - |
| AVEXIS INC | Corporate Officer/Principal | - |
Translational Medicine India, Inc.
 Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Training of Douglas E. Feltner
| University of Michigan Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| EXICURE, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Commercial Services |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Douglas E. Feltner
